Chemoinformaics analysis of Totarol methyl ether
| Molecular Weight | 300.486 | nRot | 2 |
| Heavy Atom Molecular Weight | 268.23 | nRig | 15 |
| Exact Molecular Weight | 300.245 | nRing | 3 |
| Solubility: LogS | -4.441 | nHRing | 0 |
| Solubility: LogP | 4.497 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 57.2094 |
| nHD | 0 | BPOL | 33.8386 |
| QED | 0.603 |
| Synth | 1.922 |
| Natural Product Likeliness | 0.461 |
| NR-PPAR-gamma | 0.163 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.99 |
| Pgp-sub | 0.012 |
| HIA | 0.015 |
| CACO-2 | -4.691 |
| MDCK | 0.0000271 |
| BBB | 0.532 |
| PPB | 0.990818 |
| VDSS | 0.94 |
| FU | 0.015181 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.145 |
| CYP2c19-inh | 0.95 |
| CYP2c19-sub | 0.113 |
| CYP2c9-inh | 0.849 |
| CYP2c9-sub | 0.763 |
| CYP2d6-inh | 0.068 |
| CYP2d6-sub | 0.69 |
| CYP3a4-inh | 0.184 |
| CYP3a4-sub | 0.254 |
| CL | 10.274 |
| T12 | 0.755 |
| hERG | 0.462 |
| Ames | 0.854 |
| ROA | 0.062 |
| SkinSen | 0.978 |
| Carcinogencity | 0.141 |
| EI | 0.567 |
| Respiratory | 0.645 |
| NR-Aromatase | 0.109 |
| Antiviral | No |
| Prediction | 0.80461 |